|
TBCA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.792630E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.157900E-03 |
| Normal-vs-Stage2 |
4.874500E-02 |
| Normal-vs-Stage3 |
2.007900E-02 |
| Normal-vs-Stage4 |
5.224600E-03 |
| Stage1-vs-Stage2 |
7.515800E-01 |
| Stage1-vs-Stage3 |
2.171800E-01 |
| Stage1-vs-Stage4 |
5.563300E-04 |
| Stage2-vs-Stage3 |
3.753600E-01 |
| Stage2-vs-Stage4 |
1.638400E-02 |
| Stage3-vs-Stage4 |
2.119800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.378300E-04 |
| Normal-vs-AfricanAmerican |
2.023100E-03 |
| Normal-vs-Asian |
7.416200E-02 |
| Caucasian-vs-AfricanAmerican |
7.484400E-01 |
| Caucasian-vs-Asian |
1.306770E-01 |
| AfricanAmerican-vs-Asian |
1.404030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.001200E-03 |
| Normal-vs-Female |
5.68509999999689E-05 |
| Male-vs-Female |
5.410400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.415900E-03 |
| Normal-vs-Extreme_Weight |
4.062500E-03 |
| Normal-vs-Obese |
2.322400E-03 |
| Normal-vs-Extreme_Obese |
3.780400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.091200E-01 |
| Normal_Weight-vs-Obese |
4.972800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.440000E-01 |
| Extreme_Weight-vs-Obese |
7.209400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.473400E-01 |
| Obese-vs-Extreme_Obese |
5.202400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.392500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.953800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.098100E-03 |
| Normal-vs-Age(81-100Yrs) |
7.220800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.358800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.359430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.472000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.330600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.879200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.323400E-03 |
| Normal-VS-Type2 PRCC |
1.555380E-04 |
| Normal-VS-KIRP CIMP |
5.504200E-01 |
| Normal-VS-Unclassified PRCC |
1.564400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.696000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.919600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.713200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.643800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.991900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.513000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.422900E-03 |
| Normal-vs-N1 |
5.656700E-03 |
| Normal-vs-N2 |
5.068300E-02 |
| N0-vs-N1 |
2.410000E-01 |
| N0-vs-N2 |
1.268790E-01 |
| N1-vs-N2 |
4.569000E-01 |
|
|
